All research
Orexin A 2016-09 ClinicalTrials

Liraglutide and add-on anti-diabetics investigated for inflammation, energy homeostasis in Type 2 Diabetes

The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients

Abstract

A study will observe how new add-on anti-diabetic drugs, including Liraglutide, affect inflammation and energy homeostasis in Type 2 Diabetes outpatients.


Source: clinicaltrials:NCT02885922 · Ingested 2026-06-24 · Digest: gemini-2.5-flash